Inmune Bio, Inc. (INMB) Form 424B5 — Oct 29, 2026
INmune Bio is raising approximately $4.5 million gross ($4.0 million net) by selling 3,000,000 shares at $1.50, essentially at the October 27, 2026 close of $1.52, with A.G.P./Alliance Global Partners as sole placement agent earning a 7% fee. The investor also receives 100% warrant coverage: 3,000,000 private placement warrants at a $1.65 exercise price, exercisable after April 27, 2027 and expiring in 2032, which could bring another $4.95 million if exercised. Shares outstanding rise from about 27.96 million to 30.96 million, roughly 10.7% dilution, with new investors facing immediate dilution of $0.67 per share versus pro forma book value of $0.83.
Key figures
- Debt Amount
- 0
- Gross Proceeds
- 4500000
- Offering Price
- 1.5
- Shares Offered
- 3000000
- Lock up days
- 60
- Warrant coverage
- 100% (3,000,000 warrants)
- Placement agent fee
- $315,000 (7.0% of gross)
- Net proceeds estimated
- $4.0 million
- Warrant exercise price
- $1.65
- Proceeds before expenses
- $4,185,000
- Last sale price oct 27 2026
- $1.52
- Total liabilities june 30 2026
- $6.483 million
- Shares outstanding post offering
- 30959079
- Warrant potential gross proceeds
- $4.95 million
- Cash and equivalents june 30 2026
- $18.411 million
- Immediate dilution to new investor
- $0.67 per share
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.